No abstract available
MeSH terms
-
Biosimilar Pharmaceuticals / economics*
-
Cost Savings
-
Drug Industry / economics
-
Drug Industry / organization & administration*
-
Europe
-
Humans
-
Hypoglycemic Agents / economics*
-
Insulin / economics*
-
Prospective Studies
-
United States
Substances
-
Biosimilar Pharmaceuticals
-
Hypoglycemic Agents
-
Insulin